Gastrointestinal Cancer News

Patterns of racial disparity in health-related quality of life among patients with colorectal cancer correspond with overall survival, according to research presented at the American Association for Cancer Research Annual Meeting.

Clinical response to neratinib varied by tumor and HER-2 mutation type, according to results from the global, multicenter phase 2 SUMMIT trial presented at the American Association for Cancer Research Annual Meeting.

ArQule and its partner Kyowa Hakko Kirin announced top-line results of the JET-HCC phase 3 trial for tivantinib, which did not meet its primary endpoint of progression-free survival, according to a company statement.

Overall cancer death rates continued to decrease in men, women and children among all racial and ethnic groups, according to the Annual Report to the Nation on the Status of Cancer.

Patients with gastric cancer and positive cytology or low-volume carcinomatosis experienced few postoperative complications after receiving laparoscopic preoperative hyperthermic intraperitoneal chemoperfusion, also called HIPEC, according to a clinical trial presented at the Society of Surgical Oncology Annual Cancer Symposium.

The DeGregorio Family Foundation and the Price Family Foundation have awarded a $175,000 grant to Anisa Shaker, MD, assistant professor of medicine at the Keck School of Medicine of the University of Southern California for her research on the connection between GERD and esophageal cancer risk.

The combination of gemcitabine plus capecitabine demonstrated superior survival outcomes compared with gemcitabine alone in patients with pancreatic cancer who underwent tumor resection, according to results from the ESPAC-4 trial published in The Lancet.

Imatinib treatment conferred a “durable, long-term” OS in nearly a quarter of patients with metastatic gastrointestinal stromal tumors, or GIST, according to findings published in JAMA Oncology.

In February 2000, former president Bill Clinton dedicated March as National Colon Cancer Awareness Month.

Adult survivors of adolescent and young adult cancers were more likely to experience preterm birth, low birth weight and cesarean delivery compared with births by women never diagnosed with cancer, according to study results.